Remove barriers to implementing access solutions—make healthcare more efficient and affordable with Lyfegen’s integrated solutions.
Learn more
Barriers to implementing innovative contracting agreements slow patient access.
- Conducting research is time-intensive and expensive.
- Drug-specific models are not reusable and simulating real-world scenarios can be challenging.
- Negotiations stall when payers are hesitant to adopt complex solutions.
- Data privacy and security challenges slow adoption of agreements.
An easy, secure and compliant solution to facilitate implementation of value-based contracting.
Lyfegen solutions are used by health insurances, governments, hospital payers, and pharmaceutical companies around the globe
to speed up the due diligence process, streamline collaborative drug contract design, and reduce the administrative burden of managing contracting.
Implementing contracting solutions is overwhelming.
- Manual process of identifying, calculating and claiming rebates is time and resource intensive.
- Challenging to ensure rebate and contract compliance.
- Refunds are missed reducing financial performance.
- Contracts are saved in different locations adding to the administrative burden.
Reduce administrative burden and claim every rebate.
Lyfegen solutions are trusted by health insurances, governments and hospital payers around the globe. Our easy-to-implement rebate management solutions ensure efficient rebate compliance so that you can reduce administrative tasks and focus your time and effort where it is most impactful.
.webp)
We are venture-backed, global, and independent Software-as-a-Service provider delivering innovative access, pricing, and rebate solutions to industry players, advancing affordability and access in healthcare. Discover more about Lyfegen and meet the winning team.
Learn more
We will respond within the next 24 hours.
* By sending this message, you agree to our privacy policy.
Amid the buzz of innovation at Lyfegen, we sat down with Simon, our newest team member, whose journey has brought a fresh...
Learn more
Medicaid’s launched its multiple best price program in July 2022 to address a major regulatory barrier to value-based drug...
Learn more
When pharmaceutical manufacturers share clinical and economic data about their products in the pipeline, payers can prepare...
Learn more
The U.S. Department of Health and Human Services is revamping value-based payment models, which it pursues at its so-called...
Learn more
Under value-based drug pricing, the cost of a prescription medication reflects the value of the health benefit patients receive from the...
Learn more
The news are out: we are immensely proud to be partnering with Johnson & Johnson to advance value-based healthcare and help...
Learn moreSign up & be the first to know about INNOVATIONS
* By sending this message, you agree to our privacy policy.
.webp)